The Celloxy is a medical device that applies intermittent hypoxia/hyperoxia therapy (IHHT). intermittent hypoxia/hyperoxia therapy (IHHT): a controlled training program in which the patient alternately breathes air with low, normal, and high oxygen content.
This physiological stimulus reproduces natural altitude conditions and trains cells to better adapt to stress, improving metabolic and mitochondrial efficiency, oxygenation of the body, and increasing physical performance.
At Biosalud Day Hospital we use Celloxy therapy as part of our integrative medicine and longevity protocols, as it helps restore the body's energy balance, improve mitochondrial function, and enhance self-regulation mechanisms.
It is a non-invasive, relaxing, and completely safe, supervised by medical personnel and tailored to the needs of each patient.
The Celloxy is part of various therapeutic programs at Biosalud, both for chronic conditions and preventive medicine. Its main applications include:
In patients with inflammatory, metabolic, or immune diseases, intermittent hypoxia/hyperoxia therapy helps to restore the body's adaptive capacity, improving response to treatment and the feeling of general well-being.
At Biosalud Day Hospital, each Celloxy session is integrated into a personalized medical protocol, after assessing the patient's general condition and their respiratory, cardiovascular, and metabolic function. A hypoxia test is performed beforehand so that the team can provide the most appropriate treatment for each person.
The number and frequency of sessions are adjusted according to the therapeutic objectives: from functional recovery to the optimization of health and performance.
Our goal is to retrain cells to function at peak efficiency again, helping the body to regenerate, adapt, and maintain vital energy in the long term.
